Majda Hadziahmetovic, MD was recently featured in Modern Retina discussing the warning signs of neovascular conversion in macular telangiectasia type 2 (MacTel) and the importance of early detection and timely referral.
In the Q&A, Hadziahmetovic shared insights on recognizing symptoms that may signal progression to the neovascular form of the disease, the role of multimodal imaging in diagnosis, and how the recent approval of Encelto is influencing the evaluation and management of patients with MacTel. She also discussed current approaches to treatment, challenges in clinical decision-making, and opportunities for more personalized care in the future.
Hadziahmetovic's research focuses on the early detection of retinal disease through advanced imaging, teleophthalmology, machine learning, and artificial intelligence. She holds a secondary appointment in Electrical and Computer Engineering at Duke University and continues to advance collaborative approaches to improving the diagnosis and management of retinal diseases.